Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.

Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001735276-24-000029 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-03-05	2024-03-01	ALNY	Garg Pushkal	CMO, EVP Dev, Med Affairs	A - Grant	$0.00	+4,751	13.4K	+55%	$0
D	2024-03-05	2024-03-01	ALNY	Garg Pushkal	CMO, EVP Dev, Med Affairs	A - Grant	$0.00	+9,279	9,279	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-03-01	A	A	4,751	$0.00	13,417	D	—	—	(F1) These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest over a three-year period, with one third vesting on each of the first, second and third anniversaries of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date. (F2) The Reporting Person has reported prior awards of RSUs in Table II of Form 4. The total reported in Column 5 includes the 4,751 newly awarded RSUs and 8,666 shares of common stock. The Reporting Person also holds 3,816 unvested RSUs that were previously reported in Table II.
2	Derivative	Stock Option (right to buy)	2024-03-01	A	A	9,279	$0.00	9,279	D	$152.61 · — to 2034-03-01	9,279 Common Stock	(F5) The stock option vests as to 25% of the shares on the first anniversary of the grant date and the remaining shares vesting in equal installments at the end of each successive three-month period thereafter until the fourth anniversary of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date.